With a strong focus on the significant influence that their innovations have on patients and their families, XACT Robotics is bound together by a common goal to improve patient lives for future generations. This goal-oriented strategy establishes the organization's core values and directs its future activities. Delivering innovative robotic technologies that transform patient diagnosis and treatment is at the core of this objective. With the first and only hands-free robotic system in the world, privately held XACT Robotics is leading the way in radiology advancement. This cutting-edge technology has the potential to greatly improve percutaneous treatments' targeting precision, effectiveness, and consistency. Harel Gadot, a seasoned businessman with a track record in medical robotics, founded XACT Robotics in 2013. Since then, the company has led the way in redefining image-guided percutaneous treatments. The company's philosophy is centered on the idea that every invention has a purpose and is motivated by patients and their families.

Changing Interventional Procedures. For Good.

The company's philosophy, which emphasizes great goods with a purpose, is embodied in the XACT Way. In this story, every investment bears a soul, and every product echoes with a pulse. The company's fundamental principle that determines its future course is its recognition of the transformational potential of improving patients' lives. Collaborations are essential to the growth of XACT Robotics. Every client is treated as a partner, and the business is committed to creating exceptional partnerships. The collective purpose is to promote patient care internationally, highlighting that collectively; they can have a lasting influence on patients' lives. XACT Robotics' success is ascribed to its committed workforce, which is regarded as the foundation of the business' accomplishments. The organization places a high value on giving its staff member’s chances for both professional and personal development, encouraging outstanding cooperation, and realizing that failure is a necessary component of success. XACT Robotics believes in accomplishing the seemingly impossible by relying on the team's power.

We have the power to improve patients’ lives for decades to come

As the organization looks to the future, it sees a better future in which it will continue to have the ability to enhance the lives of people for many years to come. All stakeholders and stockholders gain from XACT Robotics' active contributions to improving the healthcare system and training the next generation of leaders. From the company's founding in 2013 to receiving CE Mark approval in 2018 and FDA certification for its first-generation robotic system in 2019, their path is detailed in a timeline that highlights significant turning points. XACT Robotics is dedicated to facilitating early patient diagnosis and treatment while leading the way in cutting-edge robotic technology, opening the door for a future of revolutionary healthcare solutions.

Advancing Patient Care—Earlier

With its revolutionary approach to improving predictability and repeatability in medical treatments, the XACT ACE Robotic System is transforming the medical procedure environment and emerging as a beacon of innovation. Through the smooth execution of treatments, the ultimate objective is to greatly enhance results and increase patient satisfaction. The XACT ACE Robotic System is at the forefront of improving patient care and is essential to the early detection and management of cancer. The system is made to help reduce the number of fatalities from cancer because it understands how vital it is to identify and treat the disease early on, when tumors are smaller and easier to cure. The clinical emphasis includes organs like the liver and lungs that have intrinsic difficulties.

The effectiveness of the XACT ACE Robotic System in handling a highly mobile organ with anatomical barriers is demonstrated in the context of lung-related treatments. In order to improve patient outcomes, the system promotes early identification and treatment by offering a solution that makes it easier to access tiny and challenging-to-reach tumors.

Because of the extremely vascularized and thick tissue found deep inside the body, liver cancer, a worldwide health problem with rising incidence rates, poses a special set of difficulties. By providing a precise and safe method of accessing liver lesions, the XACT ACE Robotic System tackles these issues. Reaching lesions, particularly those in the dome becomes difficult due to the organ's movement and close proximity to important structures, such as blood arteries. The patented S Drive technology enhances the system's capacity to traverse these intricacies with lengthy and steep trajectories. Throughout the process, this technology adapts dynamically to the user's continuous trajectory changes, taking into account alterations brought on by movement. The XACT ACE Robotic System's clinical experience highlights how adaptable it is too difficult situations and provides a degree of precision that was previously difficult to attain. The system's potential influence on patient outcomes becomes clear when it precisely locates lesions in complex anatomical regions. The system's dedication to improving patient care and tackling important healthcare issues goes beyond its technological capability.

Harel Gadot the Executive Chairman & President of XACT Robotics

“We are on a mission to deliver the most cutting-edge robotic technologies that support earlier patient diagnosis and treatment.”